Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Landec Corporation

LNDC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.76
$-0.32(-3.52%)
U.S. Market opens in 15h 29m

Landec Corporation (LNDC) Stock Overview

Explore Landec Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap263.6M
P/E Ratio-10.09
EPS (TTM)$-2.17
ROE-15.33%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$6.92

LNDC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Landec Corporation (LNDC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $6.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.09 and a market capitalization of 263.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
22.69%
3-Month Change
-3.52%
6-Month Change
-21.99%
Year-to-Date (YTD) Change
N/A
1-Year Change
-23.96%
3-Year Change
-22.68%
5-Year Change
-33.38%
All-Time (Max) Change
-31.29%

Contact Information

https://www.landec.com
16503061650
5201 Great America Pkwy Ste 232, Santa Clara, CA, 93455

Company Facts

6,890 Employees
IPO DateFeb 16, 1996
CountryUS

Frequently Asked Questions